Drug recalls, 2026-W01

FDA drug recalls, December 29, 2025 to January 4, 2026

FDA posted 2 drug recalls the week of December 29, 2025: 2 Class II. Merck Sharp & Dohme LLC has the most, with 2.

License. openFDA publishes this file under CC0 1.0.

Recalls posted December 29, 2025 to January 4, 2026

Class II · Posted December 31, 2025 · Started December 12, 2025 · Ongoing

posaconazole

Product
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
Firm
Merck Sharp & Dohme LLC, Wilson, NC
Reason
Presence of particulate matter: potential presence of metal particulates in the product.
Lots
Lot#: Z012339, Z010344, Z009908, Z009909, Exp Date 12-31-2026
Quantity
845 kits
Distribution
Nationwide in the USA
RxNorm
posaconazole (RxCUI 665019, 665022, 1482908, 1482912, 1492043, +3 more)
Recall number
D-0242-2026

Class II · Posted December 31, 2025 · Started December 12, 2025 · Ongoing

aprepitant

Product
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Firm
Merck Sharp & Dohme LLC, Wilson, NC
Reason
Presence of particulate matter: potential presence of metal particulates in the product.
Lots
Lot #: Z014503, Exp 11/15/2027
Quantity
3 - single dose kits
Distribution
Nationwide in the USA
RxNorm
aprepitant (RxCUI 403810, 403811, 404465, 404466, 644088, +5 more)
Recall number
D-0241-2026

Source: openFDA drug enforcement reports, as of October 14, 2026. Publisher page

About this data

Each row is one FDA drug enforcement report: one product from one firm. A week here is Monday to Sunday, keyed on the date FDA listed the recall in its weekly Enforcement Report. The date the firm started the recall is shown on each row and is often weeks earlier.

Class I means use of the product could cause serious health problems or death. Class II means it could cause temporary or reversible health problems. Class III means it is unlikely to cause health problems. RxNorm names and RxCUIs come from openFDA's match of the product to its drug label. Compounded products often have no match.

This page lists public records. It is not medical advice. Check the FDA record before acting on a recall.

Source: openFDA drug enforcement reports, as of October 14, 2026. Publisher page

Run it in Rivvi

Get this every Monday

Rivvi pulls the FDA drug recalls posted in the last 7 days and sends you the list each Monday morning. Add the drugs you care about and it flags any that match.

Watch recalls in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams, with the weekly watch turned on.

Try it on your own data today.

Free to start. Most teams are using it the same day.

Get started for freeSee pricing
FDA drug recalls, December 29, 2025 to January 4, 2026 (2026-W01): 2 recalls · Rivvi